Monashee Investment Management »

Aura Biosciences shares owned by Monashee Investment Management

Quarter-by-quarter ownership of Aura Biosciences (AURA) shares owned by Monashee Investment Management from 13F filings

Historical chart of Monashee Investment Management investment in Aura Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Aura Biosciences held by Monashee Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aura Biosciences by Monashee Investment Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.8M 198k 8.86
2022-12-31 $1.4M 132k 10.50

More positions owned by Monashee Investment Management

Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Core Msci Eafe (IEFA)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Ishares Core Msci Emkt (IEMG)
Ishares Tr Core S&p Ttl Stk (ITOT)
Vanguard Index Fds Total Stk Mkt (VTI)
Structure Therapeutics Sponsored Ads (GPCR)
Aercap Holdings Nv SHS (AER)
PG&E Corporation (PCG)
Korro Bio (KRRO)
Eyepoint Pharmaceuticals Com New (EYPT)
Celldex Therapeutics Com New (CLDX)
Roivant Sciences SHS (ROIV)

View all positions for Monashee Investment Management

Top funds holding Aura Biosciences

Eventide Asset Management
Citadel Advisors
Medicxi Ventures Management
Vanguard Group
Nantahala Capital Management
Goldman Sachs Group
Regency Capital Management
T. Rowe Price Associates
Franklin Resources
Decheng Capital
Long Focus Capital Management
Monashee Investment Management
Dimensional Fund Advisors
TD Asset Management
Levin Capital Strategies

View all funds holding Aura Biosciences